[Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators]
- PMID: 3208692
[Induction of the antileukemic activity in nonimmune allogeneic splenocytes using spleen hemoregulators]
Abstract
The leukemic mice treated with cyclophosphamide were injected twice a week with the allogenic splenocytes treated for 4 h with the substance isolated from the calf spleen. The leukemia growth inhibition was observed. Syngenic splenocytes were inactive. Allogenic but not syngenic splenocytes manifested a certain antileukemic activity observed in the Winn neutralization and 51Cr release tests, however this activity did not correlate quantitatively with more pronounced antileukemic action of cells in vivo.
Similar articles
-
Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.Cancer Res. 1977 Oct;37(10):3494-6. Cancer Res. 1977. PMID: 20223
-
Graft versus leukemia without fatal graft-versus-host disease in AKR mice.Cancer Res. 1975 Mar;35(3):637-9. Cancer Res. 1975. PMID: 234789
-
[Natural killer activity of splenocytes of C3HA mice in the early period after transplantation of hepatoma 22a cells].Eksp Onkol. 1987;9(6):52-5. Eksp Onkol. 1987. PMID: 3436291 Russian.
-
Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.J Immunol. 1986 Dec 1;137(11):3675-80. J Immunol. 1986. PMID: 3491145
-
Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems.Ann N Y Acad Sci. 1976;277(00):492-504. doi: 10.1111/j.1749-6632.1976.tb41723.x. Ann N Y Acad Sci. 1976. PMID: 793486 Review. No abstract available.